Abstract
Purpose of Review Combination antiretroviral therapy (cART) does not act on latent HIV reservoirs, and no latency-reversing agent (LRA) to date consistently reduces viral reservoirs in humans. In Sub-Saharan Africa and elsewhere, complementary and alternative medicines (CAM) are traditionally used to manage HIV/AIDS, including a subset with LRA properties. Recent Findings Several plants from the Euphorbiaceae and Thymelaeaceae families have been recently documented for traditional HIV/AIDS management and contain LRAs that function through protein kinase C activation. These CAM are increasingly validated in HIV-infected primary cells and humanized mice. Engagement with traditional health practitioners (THPs) which prioritizes data and benefits sharing can improve trust relations, build long-term collaborations, and advance mutual knowledge on these unique CAM. Summary CAM used traditionally for HIV/AIDS management include LRAs already used by humans, but more study and collaboration with THPs are needed to understand their potential to support global cART-free HIV remission and cure efforts.
Funding Information
  • Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
  • Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
  • Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
  • Canadian Institutes of Health Research (PJT-153057)
  • Canadian Institutes of Health Research (PJT-153057)
  • W. W. Smith Charitable Trust (A2301)
  • Penn Center for AIDS Research (P30 AI 045008)

This publication has 65 references indexed in Scilit: